Q32 Bio Inc. (FIXX) Deferred Tax Assets, Valuation Allowance USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Q32 Bio Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2017 to 2023.
  • Q32 Bio Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $221 M, a 23.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $221 M +$41.7 M +23.2% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $180 M +$16.3 M +9.95% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $163 M +$38.4 M +30.7% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $125 M +$47.2 M +60.7% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $77.8 M +$40.2 M +107% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $37.6 M +$25.1 M +201% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $12.5 M Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.